These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6019354)

  • 1. A comparison of the effects of tolazamide and tolbutamide upon blood glucose and serum insulin and lipid levels in diabetic subjects.
    Moorhouse JA
    Can Med Assoc J; 1967 Mar; 96(9):536-9. PubMed ID: 6019354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of oral hypoglycemic agents. VI. Comparative study on acute oral overload using tolbutamide and tolazamide in normal and diabetic subjects. Various aspects of the prolonged use of tolazamide in comparison with other sulfonylureas].
    Pereira VG; Wajchenberg BL; Shnaider J
    Arq Bras Endocrinol Metabol; 1965 Aug; 14(2):133-42. PubMed ID: 5322747
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypoglycemic and hypotriglyceridemic effects of tolbutamide in triphenyltin chloride-induced diabetic rabbits.
    Watanabe M; Watanabe K; Matsui H
    Vet Hum Toxicol; 2002 Jun; 44(3):140-4. PubMed ID: 12046964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid, glucose, and insulin interrelationships in normal, prediabetic, and chemical diabetic subjects.
    Kyner JL; Levy RI; Soeldner JS; Gleason RE; Fredrickson DS
    J Lab Clin Med; 1976 Sep; 88(3):345-58. PubMed ID: 956689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoglycemic drugs.
    Stehling L
    Clin Anesth; 1974; 10(1):233-47. PubMed ID: 4598996
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin response to glucose, tolbutamide, secretin, and isoprenaline in maturity-onset diabetes mellitus.
    Deckert T; Lauridsen UB; Madsen SN; Mogensen P
    Dan Med Bull; 1972 Oct; 19(7):222-6. PubMed ID: 5079926
    [No Abstract]   [Full Text] [Related]  

  • 7. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of insulin and glucose in the induction of hypoaminoacidemia in man: studies in normal, juvenile diabetic, and insuloma patients.
    Adibi SA; Morse EL; Amin PM
    J Lab Clin Med; 1975 Sep; 86(3):395-409. PubMed ID: 168278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum insulin assay: an important therapeutic tool in management of freshly diagnosed type 2 diabetes mellitus.
    Saxena T; Maheshwari S; Goyal RK
    J Assoc Physicians India; 2000 Aug; 48(8):815-7. PubMed ID: 11273476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long term sulfonylurea therapy on plasma insulin and fasting lipid levels.
    Podolsky S; Burney SW
    Diabete Metab; 1979 Jun; 5(2):113-7. PubMed ID: 478080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proportion of low insulin responders to glucose among the offspring of maturity-onset diabetics (author's transl)].
    Vague P; Ramahandridona G; Vague J
    Diabete Metab; 1975 Mar; 1():45-50. PubMed ID: 1234066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical study of the metabolic effect of a new oral hypoglycemic agent: glipizide.
    Iacono G; Ghionni A; Colucci M; Verde G; Caputo G
    Int J Clin Pharmacol; 1974 Apr; 7(3):225-31. PubMed ID: 4850166
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of the possible interaction of indoprofen with hypoglycemic sulfonylureas in diabetic patients.
    Pedrazzi F; Bommartini F; Freddo J; Emanueli A
    Eur J Rheumatol Inflamm; 1981; 4(1):26-31. PubMed ID: 7042358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral treatment of diabetes mellitus with the new sulfonylurea tolazamide].
    Vogel G; Krummel E
    Arzneimittelforschung; 1969 Jul; 19(7):1128-30. PubMed ID: 5394514
    [No Abstract]   [Full Text] [Related]  

  • 15. Defective acute insulin secretion in diabetics. Differences between normal weight and obese subjects.
    Vague P; Ramahandridona G; Vialettes B; Raymond JP; Vague J
    Diabete Metab; 1978 Dec; 4(4):261-5. PubMed ID: 729892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics.
    Schmeltz R; Wendorff HJ; Field JB
    J Clin Endocrinol Metab; 1978 Apr; 46(4):519-27. PubMed ID: 755038
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of short-term clofibrate on glucose metabolism and insulin secretion in patients with mild maturity-onset diabetes mellitus.
    Ferrari C; Romussi M; Bertazzoni A; Testori GP; Grimaldi MG
    Biomedicine; 1978 Jun; 29(4):133-6. PubMed ID: 556385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-diabetic property of ethanolic extract of Andrographis paniculata in streptozotocin-diabetic rats.
    Zhang XF; Tan BK
    Acta Pharmacol Sin; 2000 Dec; 21(12):1157-64. PubMed ID: 11603293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute hypoglycemizing activity of intravenous tolazamide and tolbutamide: comparative study in normal, diabetic and hepatopathic man. Preliminary note].
    Milani R
    Minerva Med; 1965 Sep; 56(74):3163-5. PubMed ID: 5833700
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of an ethanolic extract of Gynura procumbens on serum glucose, cholesterol and triglyceride levels in normal and streptozotocin-induced diabetic rats.
    Zhang XF; Tan BK
    Singapore Med J; 2000 Jan; 41(1):9-13. PubMed ID: 10783673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.